Emmessar Biotech & Nutrition Limited has submitted a regulatory filing to the Bombay Stock Exchange Limited regarding an upcoming board meeting. The filing is made pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 31, 2026, in Mumbai. The primary agenda item for this meeting is to consider and approve the unaudited Financial Results of the Company for the quarter ended September 30, 2026.
Additionally, the Company has confirmed that the Trading Window for trading in equity shares of the Company will remain closed until November 2, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and follows the previous intimation provided to the exchange via letter dated September 29, 2026.